Postmenopausal Bleeding: Why Even One Episode Needs Assessment
Key message: Any vaginal bleeding after 12 consecutive months without a natural period is postmenopausal bleeding and should…
Key message: Any vaginal bleeding after 12 consecutive months without a natural period is postmenopausal bleeding and should be assessed promptly. Most causes are benign, but the amount or colour cannot identify the cause.
Get urgent help: Seek urgent care for heavy bleeding, dizziness or fainting, severe pelvic or abdominal pain, breathlessness, chest pain, marked weakness, fever or rapid deterioration. Light stable spotting still needs a prompt appointment.
What counts as postmenopausal bleeding?
The definition applies after 12 months without a natural period. Do not wait for a second episode before arranging assessment.
- Fresh red blood or brown blood.
- Light spotting noticed only once.
- Pink, blood-stained or watery vaginal discharge.
- Bleeding after sex.
- New unexpected bleeding while using menopausal hormone therapy.
Does it usually mean cancer?
No. Many causes are benign. RCOG patient information notes that about 9 in 10 patients with postmenopausal bleeding do not have cancerous cells in the uterine lining.
However, roughly 1 in 10 may have endometrial cancer cells, and cancer of the cervix or vagina is another less common possibility. Prompt assessment is therefore important even when bleeding is very light.
What are the common causes?
- Thinning and fragility of the vaginal or uterine lining after estrogen levels fall.
- Endometrial or cervical polyps.
- Bleeding related to menopausal hormone therapy.
- Endometrial hyperplasia, which may or may not contain atypical cells.
- Cancer of the uterus, cervix or vagina less commonly.
- A source from the urinary tract or bowel mistaken for vaginal bleeding.
What information should I give the clinician?
- The date, amount, colour and duration of bleeding and whether it followed sex.
- Whether you are certain the blood came from the vagina rather than urine or the bowel.
- HRT type, dose, start date, recent changes and whether tablets or patches are used as prescribed.
- Tamoxifen, anticoagulants and all other medicines.
- Pelvic pain, unusual discharge, urinary or bowel symptoms, weight loss or reduced appetite.
- Diabetes, PCOS/PMOS, obesity, previous endometrial hyperplasia and relevant family history.
What examination may be offered?
Assessment may include abdominal examination and a speculum examination to look at the vagina and cervix. Cervical screening is not a test for endometrial cancer, but an overdue cervical test or visible cervical abnormality may need separate attention.
You can request a chaperone and ask for the examination to stop at any time.
What does the ultrasound assess?
A transvaginal ultrasound measures the endometrial lining and looks for polyps, fibroids, ovarian or pelvic findings. It is usually brief but may cause discomfort.
The lining measurement is interpreted with HRT type, image quality, bleeding pattern and risk factors. A thin lining lowers the likelihood of endometrial cancer but does not automatically explain persistent or recurrent bleeding.
When are hysteroscopy and biopsy used?
Hysteroscopy uses a thin telescope to look inside the uterus. A biopsy may be taken at the same visit. Pain experience varies, and options for pain relief, stopping the procedure or having anaesthesia should be discussed.
- When the lining is thicker than expected or cannot be assessed clearly.
- When a polyp or focal lesion is suspected.
- When bleeding persists or recurs despite a reassuring initial scan.
- When risk factors or the clinical picture make tissue diagnosis important.
What if I use HRT?
Unscheduled bleeding can occur soon after starting HRT or changing the preparation. It should still be discussed rather than assumed to be harmless.
The 2026 British Menopause Society pathway considers timing, bleeding severity, HRT regimen and endometrial-cancer risk factors. Low-risk bleeding soon after starting or changing treatment may be managed initially by reviewing adherence and adjusting progestogen or the preparation, while heavy, persistent, late-onset or higher-risk bleeding needs prompt ultrasound or an urgent pathway.
Do not stop or change prescribed HRT without advice unless the treating clinician instructs you.
What treatment may be needed?
Treatment is based on the cause; the investigation should not be delayed by trying multiple unprescribed remedies.
- No treatment after a normal assessment when bleeding settles.
- Vaginal estrogen for atrophic vaginal changes when appropriate.
- Removal of a polyp.
- Adjustment of HRT or progestogen.
- Treatment of endometrial hyperplasia according to whether atypia is present.
- Referral to a gynaecological cancer team when cancer is suspected or confirmed.
What if the bleeding stops before my appointment?
Keep the appointment. A single episode still needs assessment, and stopping does not identify the cause.
If the bleeding becomes heavy or you develop pain, faintness, fever or breathlessness, seek urgent care instead of waiting.
Frequently asked questions
Does one small spot really need assessment?
Yes. Any vaginal bleeding after 12 months without a natural period should be reviewed.
Does bleeding mean I have cancer?
No. Most patients do not, but assessment is needed because early cancer and precancer can cause light bleeding.
Can HRT cause bleeding?
Yes, especially after starting or changing it, but the timing, pattern and risk factors determine whether adjustment or investigation is needed.
Is a transvaginal ultrasound painful?
It is usually brief and may cause mild discomfort. You can ask for it to stop at any time.
If the ultrasound is normal, can I ignore future bleeding?
No. Persistent or recurrent bleeding needs reassessment even after a reassuring initial result.
Your next step
Arrange a prompt gynaecology assessment after any postmenopausal bleeding. Bring a medication and HRT list and previous ultrasound, biopsy or hysteroscopy reports. Heavy bleeding, faintness or severe pain needs urgent care.
Medical and content review: Dr Mohamed Abdelghany, Obstetrics & Gynecology Specialist, MRCOG (UK), MSc Obstetrics & Gynecology – Kasr Al-Ainy, Cairo University.
Last reviewed: 22 August 2026.
This information is for general education and does not replace individual medical assessment. Severe, sudden or concerning symptoms should not wait for a routine appointment.
